PRKN and breast cancer: Consistently, we found that Parkin protein levels were significantly lower in breast cancer samples (n = 120) compared with non-tumor breast tissues (n = 48) in a tissue microarray (TMA; TMA-BR2082a from US Biomax) as examined by immunohistochemistry (IHC) staining (Fig. 1a).